Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 413

1.

Subungual melanoma: management considerations.

Cohen T, Busam KJ, Patel A, Brady MS.

Am J Surg. 2008 Feb;195(2):244-8.

PMID:
18086464
[PubMed - indexed for MEDLINE]
2.

Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes.

Ellis MC, Weerasinghe R, Corless CL, Vetto JT.

Am J Surg. 2010 May;199(5):663-8. doi: 10.1016/j.amjsurg.2010.01.019.

PMID:
20466113
[PubMed - indexed for MEDLINE]
3.

Desmoplastic and neurotropic melanoma.

Su LD, Fullen DR, Lowe L, Wang TS, Schwartz JL, Cimmino VM, Sondak VK, Johnson TM.

Cancer. 2004 Feb 1;100(3):598-604.

PMID:
14745878
[PubMed - indexed for MEDLINE]
Free Article
4.

Factors predictive of nonsentinel lymph node involvement and clinical outcome in melanoma patients with metastatic sentinel lymph node.

Rossi CR, De Salvo GL, Bonandini E, Mocellin S, Foletto M, Pasquali S, Pilati P, Lise M, Nitti D, Rizzo E, Montesco MC.

Ann Surg Oncol. 2008 Apr;15(4):1202-10. doi: 10.1245/s10434-007-9734-8. Erratum in: Ann Surg Oncol. 2008 May;15(5):1552.

PMID:
18165880
[PubMed - indexed for MEDLINE]
5.

Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.

Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W.

Ann Surg Oncol. 2006 Dec;13(12):1655-63. Epub 2006 Oct 3.

PMID:
17016755
[PubMed - indexed for MEDLINE]
6.

Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy.

Dalal KM, Patel A, Brady MS, Jaques DP, Coit DG.

Ann Surg Oncol. 2007 Jun;14(6):1934-42. Epub 2007 Apr 4.

PMID:
17406951
[PubMed - indexed for MEDLINE]
7.

Surgical management and prognostic factors in patients with subungual melanoma.

Heaton KM, el-Naggar A, Ensign LG, Ross MI, Balch CM.

Ann Surg. 1994 Feb;219(2):197-204.

PMID:
8129491
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.

Roka F, Mastan P, Binder M, Okamoto I, Mittlboeck M, Horvat R, Pehamberger H, Diem E.

Eur J Surg Oncol. 2008 Jan;34(1):82-8. Epub 2007 Mar 13.

PMID:
17360144
[PubMed - indexed for MEDLINE]
9.

Subungual melanoma.

Krige JE, Hudson DA, Johnson CA, King HS, Chetty R.

S Afr J Surg. 1995 Mar;33(1):10-4.

PMID:
7631249
[PubMed - indexed for MEDLINE]
10.

Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.

Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.

Arch Dermatol. 2009 Oct;145(10):1105-13. doi: 10.1001/archdermatol.2009.209.

PMID:
19841396
[PubMed - indexed for MEDLINE]
11.
12.

Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.

Fairbairn NG, Orfaniotis G, Butterworth M.

J Plast Reconstr Aesthet Surg. 2012 Oct;65(10):1396-402. doi: 10.1016/j.bjps.2012.04.019. Epub 2012 May 1.

PMID:
22552263
[PubMed - indexed for MEDLINE]
13.

Regional recurrence after negative sentinel lymph node biopsy for melanoma.

Carlson GW, Page AJ, Cohen C, Parker D, Yaar R, Li A, Hestley A, Delman KA, Murray DR.

Ann Surg. 2008 Sep;248(3):378-86. doi: 10.1097/SLA.0b013e3181855718.

PMID:
18791358
[PubMed - indexed for MEDLINE]
14.

Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.

Wong SL, Morton DL, Thompson JF, Gershenwald JE, Leong SP, Reintgen DS, Gutman H, Sabel MS, Carlson GW, McMasters KM, Tyler DS, Goydos JS, Eggermont AM, Nieweg OE, Cosimi AB, Riker AI, G Coit D.

Ann Surg Oncol. 2006 Jun;13(6):809-16. Epub 2006 Apr 12.

PMID:
16604476
[PubMed - indexed for MEDLINE]
15.

Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database.

Mandalà M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, Barberis M, Marchesi L, Poletti P, Bonomi L, Novellino L, Di Biagio K, Milesi A, Guerra U, Tondini C.

Eur J Cancer. 2009 Sep;45(14):2537-45. doi: 10.1016/j.ejca.2009.05.034. Epub 2009 Jun 22.

PMID:
19553103
[PubMed - indexed for MEDLINE]
16.

Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience.

Sánchez-Ortiz R, Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway CA.

J Urol. 2005 Jun;173(6):1958-65.

PMID:
15879790
[PubMed - indexed for MEDLINE]
17.

Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy.

Sabel MS, Griffith KA, Arora A, Shargorodsky J, Blazer DG 3rd, Rees R, Wong SL, Cimmino VM, Chang AE.

Surgery. 2007 Jun;141(6):728-35.

PMID:
17560249
[PubMed - indexed for MEDLINE]
18.

Vulvar melanoma reconsidered.

Look KY, Roth LM, Sutton GP.

Cancer. 1993 Jul 1;72(1):143-6.

PMID:
8508398
[PubMed - indexed for MEDLINE]
19.

Does sentinel lymph node biopsy in cutaneous head and neck melanoma alter disease outcome?

Doting EH, de Vries M, Plukker JT, Jager PL, Post WJ, Suurmeijer AJ, Hoekstra HJ.

J Surg Oncol. 2006 Jun 1;93(7):564-70.

PMID:
16705724
[PubMed - indexed for MEDLINE]
20.

Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.

Morris KT, Busam KJ, Bero S, Patel A, Brady MS.

Ann Surg Oncol. 2008 Jan;15(1):316-22. Epub 2007 Nov 15.

PMID:
18004626
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk